Journal article

28095 Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment

Andrew Blauvelt, Kenneth B Gordon, Christopher EM Griffiths, Kim A Papp, Peter Foley, Michael Song, Megan Miller, Yaung-Kaung Shen, Yin You, Paraneedharan Ramachandran, Kristian Reich

Journal of the American Academy of Dermatology | Elsevier BV | Published : 2021